Greenspon et al.1616 Greenspon AJ, Le KY, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, et al. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014;7(6):541-9.]
|
129 |
Percutaneous: 112 Surgery: 17 |
Majors: 4.6 Minors: - |
10.8 |
6 |
14.5 |
Rickard et al.[1414 Rickard J, Tarakji K, Cheng A, Spragg D, Cantillon DJ, Martin DO, et al. Survival of patients with biventricular devices after device infection, extraction, and reimplantation. JACC Heart Fail. 2013;1(6):508-13.]
|
151 |
Percutaneous: 151 Surgery: |
- |
6.6 |
24 |
- |
Ipek et al. [2020 Ipek EG, Guray U, Demirkan B, Guray Y, Aksu T. Infections of implantable cardiac rhythm devices: predisposing factors and outcome. Acta Cardiol. 2012;67(3):303-10.]
|
34 |
Percutaneous: 28 Surgery: 5 |
Majors: 2.9 Minors: 14.7 |
8.8 |
- |
- |
Pichlmaier et al.[2525 Pichlmaier M, Knigina L, Kutschka I, Bara C, Oswald H, Klein G, et al. Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection. J Thorac Cardiovasc Surg. 2011;142(6):1482-90.]
|
178 |
Percutaneous: 144 Surgery: 34 |
Majors: 2.2 Minors: 14.0 |
3.9 |
Average of 55 |
18.5 |
Knigina et al.[1717 Knigina L, Kühn C, Kutschka I, Oswald H, Klein G, Haverich A, et al. Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. Europace. 2010;12(9):1275-81.]
|
192 |
Percutaneous: 155 Surgery: 37 |
- |
3.6 |
66 |
13.5 |
Grammes et al.[2121 Grammes JA, Schulze CM, Al-Bataineh M, Yesenosky GA, Saari CS, Vrabel MJ, et al. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram. J Am Coll Cardiol. 2010;55(9):886-94.]
|
100 |
Percutaneous: 100 Surgery: - |
Majors: 2.0 Minors: 3.0 |
10.0 |
14.5 |
12.7 |
Tarakji et al.[2626 Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16(10):1490-5.]
|
502 |
Percutaneous: 502 Surgery: - |
- |
5.0 |
12 |
20.3 |
Amraoui et al.[1212 Amraoui S, Barandon L, Whinnett Z, Ploux S, Labrousse L, Denis A, et al. Single surgical procedure combining epicardial pacemaker implantation and subsequent extraction of the infected pacing system for pacemaker-dependent patients. J Thorac Cardiovasc Surg. 2013;146(2):302-5.]
|
100 |
Percutaneous: 100 Surgery: 2 |
Majors: 2.0 Minors: 6.0 |
2.0 |
12 |
4.0 |
Greenspon et al.[1818 Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012;59(7):681-7. 59...
]
|
145 |
Percutaneous: 145 Surgery: - |
Majors: 4.8 Minors: - |
6.2 |
6 |
27.6 |
Cengiz et al.[1515 Cengiz M, Okutucu S, Ascioglu S, Şahin A, Aksoy H, Sinan Deveci O, et al. Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center. Clin Cardiol. 2010;33(7):406-11.]
|
57 |
Percutaneous: 17 Surgery: 18 |
- |
3.5 |
- |
- |
Baman et al.[1919 Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2(2):129-34.]
|
210 |
Percutaneous: 170 Surgery: 17 |
Majors: 4.8 Minors:12.3 |
8.1 |
6 |
18.0 |
Goya et al.[2222 Goya M, Nagashima M, Hiroshima K, Hayashi K, Makihara Y, Fukunaga M, et al. Lead extractions in patients with cardiac implantable electronic device infections: single center experience. J Arrhythm. 2016;32(4):308-12.]
|
183 |
Percutaneous: 183 Surgery: 4 |
Majors: 2.7 Minors: 3.8 |
2.2 |
- |
- |
Deharo et al.[1313 Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart. 2012;98(9):724-31.]
|
197 |
Percutaneous: 189 Surgery: 13 |
Majors: 1.0 Minors: 12.2 |
4.1 |
Average of 25 |
1 year: 14.3 5 years: 35.4 |
Le et al.[2424 Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al; Mayo Cardiovascular Infections Study Group. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678-85.]
|
416 |
Percutaneous: 325 Surgery: 91 |
Majors: 4.1 Minors: 6.5 |
5.5 |
12 |
14.7 |
Gomes et al.[2323 Gomes S, Cranney G, Bennett M, Giles R. Lead extraction for treatment of cardiac device infection: a 20-year single centre experience. Heart Lung Circ. 2017;26(3):240-5.]
|
348 |
Percutaneous: 348 Surgery: - |
- |
2.0 |
66 |
- |
Tarakji et al.[2727 Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010;7(8):1043-7.]
|
412 |
Percutaneous: 412 Surgery: - |
Majors: 0.5 Minors: 3.4 |
4.6 |
6 |
17.0 |
Total |
3354 |
Percutaneous: 3081 Surgery: 238 |
- |
- |
- |
- |
Mean |
209.6 |
- |
Majors: 2.9 Minors: 8.4 |
5.4 |
24 |
- |